Kasiani C Myers

Summary

Affiliation: Cincinnati Children's Hospital Medical Center
Country: USA

Publications

  1. ncbi High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients
    Kasiani C Myers
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center and University of Cincinnati, OH 45229, USA
    Biol Blood Marrow Transplant 19:500-3. 2013
  2. ncbi Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update
    Kasiani C Myers
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center, University of Cincinnati, 3333 Burnet Avenue, MLC 7015, Cincinnati, OH 45229, USA
    Hematol Oncol Clin North Am 27:117-28, ix. 2013
  3. ncbi Impaired immune function in children with Fanconi anaemia
    Kasiani C Myers
    Divisions of Bone Marrow Transplant and Immune Deficiency, Department of Pediatrics, Cincinnati Children s Hospital and Medical Center, Cincinnati, OH 45229, USA
    Br J Haematol 154:234-40. 2011
  4. ncbi The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations
    Kasiani Myers
    Cincinnati Children s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
    Pediatr Blood Cancer 58:462-5. 2012
  5. ncbi Endocrine phenotype of children and adults with Fanconi anemia
    Susan R Rose
    Division of Endocrinology, Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio 45229, USA
    Pediatr Blood Cancer 59:690-6. 2012
  6. ncbi The FA pathway counteracts oxidative stress through selective protection of antioxidant defense gene promoters
    Wei Du
    Divisions of Experimental Hematology and Cancer Biology, Cincinnati Children s Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229, USA
    Blood 119:4142-51. 2012

Detail Information

Publications6

  1. ncbi High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients
    Kasiani C Myers
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center and University of Cincinnati, OH 45229, USA
    Biol Blood Marrow Transplant 19:500-3. 2013
    ..We conclude that high-dose steroid therapy if initiated early may reverse VOD of the liver in pediatric HSCT patients, abrogating the need for defibrotide therapy with its associated toxicities and regulatory difficulties...
  2. ncbi Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update
    Kasiani C Myers
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center, University of Cincinnati, 3333 Burnet Avenue, MLC 7015, Cincinnati, OH 45229, USA
    Hematol Oncol Clin North Am 27:117-28, ix. 2013
    ..This article summarizes the clinical phenotype of SDS, diagnostic and treatment approaches, and novel advances in our understanding of the molecular pathophysiology of this disease...
  3. ncbi Impaired immune function in children with Fanconi anaemia
    Kasiani C Myers
    Divisions of Bone Marrow Transplant and Immune Deficiency, Department of Pediatrics, Cincinnati Children s Hospital and Medical Center, Cincinnati, OH 45229, USA
    Br J Haematol 154:234-40. 2011
    ..These findings may be especially relevant in this patient population with known predisposition to DNA damage and malignancy...
  4. ncbi The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations
    Kasiani Myers
    Cincinnati Children s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
    Pediatr Blood Cancer 58:462-5. 2012
    ....
  5. ncbi Endocrine phenotype of children and adults with Fanconi anemia
    Susan R Rose
    Division of Endocrinology, Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio 45229, USA
    Pediatr Blood Cancer 59:690-6. 2012
    ..We sought to further characterize the endocrine phenotype in children and adults with FA...
  6. ncbi The FA pathway counteracts oxidative stress through selective protection of antioxidant defense gene promoters
    Wei Du
    Divisions of Experimental Hematology and Cancer Biology, Cincinnati Children s Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229, USA
    Blood 119:4142-51. 2012
    ..In addition, oxidative stress-induced FANCD2 ubiquitination is required for the formation of a FA-BRG1-promoter complex. Taken together, these data identify a role for the FA pathway in cellular antioxidant defense...